de Commonwealth Equity Services Invesco Pharmaceuticals ETF PJP Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 981 k | Vender |
8,285
-2,020
| -20% | -USD 219 k | ﹤0.01% | 2727 |
|
|
2026
Q1 | USD 1.07 M | Vender |
10,305
-442
| -4% | -USD 46.7 k | ﹤0.01% | 2562 |
|
|
2025
Q4 | USD 1.12 M | Comprar |
10,747
+635
| +6% | +USD 63.9 k | ﹤0.01% | 2481 |
|
|
2025
Q3 | USD 935 k | Vender |
10,112
-1,832
| -15% | -USD 160 k | ﹤0.01% | 2649 |
|
|
2025
Q2 | USD 954 k | Vender |
11,944
-5,308
| -31% | -USD 424 k | ﹤0.01% | 2609 |
|
|
2025
Q1 | USD 1.49 M | Vender |
17,252
-124
| -0.7% | -USD 10.6 k | ﹤0.01% | 2147 |
|
|
2024
Q4 | USD 1.44 M | Vender |
17,376
-92
| -0.5% | -USD 7.92 k | ﹤0.01% | 2121 |
|
|
2024
Q3 | USD 1.52 M | Vender |
17,468
-4,423
| -20% | -USD 378 k | ﹤0.01% | 2025 |
|
|
2024
Q2 | USD 1.8 M | Vender |
21,891
-522
| -2% | -USD 41.5 k | ﹤0.01% | 1856 |
|
|
2024
Q1 | USD 1.8 M | Vender |
22,413
-2,526
| -10% | -USD 196 k | ﹤0.01% | 1851 |
|
|
2023
Q4 | USD 1.9 M | Vender |
24,939
-1,009
| -4% | -USD 72.1 k | ﹤0.01% | 1739 |
|
|
2023
Q3 | USD 1.88 M | Vender |
25,948
-545
| -2% | -USD 41.8 k | ﹤0.01% | 1643 |
|
|
2023
Q2 | USD 2 M | Comprar |
26,493
+444
| +2% | +USD 33.9 k | ﹤0.01% | 1614 |
|
|
2023
Q1 | USD 1.98 M | Vender |
26,049
-313
| -1% | -USD 24.1 k | ﹤0.01% | 1566 |
|
|
2022
Q4 | USD 2.07 M | Comprar |
26,362
+778
| +3% | +USD 59.8 k | 0.01% | 1475 |
|
|
2022
Q3 | USD 1.82 M | Comprar |
25,584
+726
| +3% | +USD 54.1 k | ﹤0.01% | 1481 |
|
|
2022
Q2 | USD 1.86 M | Vender |
24,858
-1,738
| -7% | -USD 132 k | ﹤0.01% | 1482 |
|
|
2022
Q1 | USD 2.12 M | Comprar |
26,596
+6,110
| +30% | +USD 474 k | ﹤0.01% | 1469 |
|
|
2021
Q4 | USD 1.66 M | Vender |
20,486
-1,787
| -8% | -USD 141 k | ﹤0.01% | 1620 |
|
|
2021
Q3 | USD 1.72 M | Vender |
22,273
-960
| -4% | -USD 77.4 k | ﹤0.01% | 1527 |
|
|
2021
Q2 | USD 1.87 M | Vender |
23,233
-79
| -0.3% | -USD 6.27 k | ﹤0.01% | 1470 |
|
|
2021
Q1 | USD 1.84 M | Vender |
23,312
-3,640
| -14% | -USD 284 k | 0.01% | 1387 |
|
|
2020
Q4 | USD 1.92 M | Vender |
26,952
-3,894
| -13% | -USD 261 k | 0.01% | 1261 |
|
|
2020
Q3 | USD 1.97 M | Comprar |
30,846
+200
| +0.7% | +USD 13.1 k | 0.01% | 1109 |
|
|
2020
Q2 | USD 1.98 M | Comprar |
30,646
+1,075
| +4% | +USD 66.8 k | 0.01% | 1035 |
|
|
2020
Q1 | USD 1.63 M | Vender |
29,571
-1,370
| -4% | -USD 83.4 k | 0.01% | 992 |
|
|
2019
Q4 | USD 2 M | Vender |
30,941
-3,087
| -9% | -USD 188 k | 0.01% | 1034 |
|
|
2019
Q3 | USD 1.93 M | Vender |
34,028
-9,240
| -21% | -USD 532 k | 0.01% | 995 |
|
|
2019
Q2 | USD 2.6 M | Vender |
43,268
-1,423
| -3% | -USD 87.3 k | 0.01% | 839 |
|
|
2019
Q1 | USD 2.91 M | Vender |
44,691
-5,185
| -10% | -USD 341 k | 0.01% | 755 |
|
|
2018
Q4 | USD 3.11 M | Vender |
49,876
-2,742
| -5% | -USD 185 k | 0.02% | 648 |
|
|
2018
Q3 | USD 3.87 M | Vender |
52,618
-1,968
| -4% | -USD 141 k | 0.02% | 621 |
|
|
2018
Q2 | USD 3.67 M | Vender |
54,586
-2,736
| -5% | -USD 176 k | 0.02% | 624 |
|
|
2018
Q1 | USD 3.58 M | Vender |
57,322
-6,468
| -10% | -USD 426 k | 0.02% | 606 |
|
|
2017
Q4 | USD 4.09 M | Vender |
63,790
-4,354
| -6% | -USD 279 k | 0.02% | 541 |
|
|
2017
Q3 | USD 4.45 M | Vender |
68,144
-9,101
| -12% | -USD 575 k | 0.03% | 484 |
|
|
2017
Q2 | USD 4.85 M | Vender |
77,245
-9,027
| -10% | -USD 542 k | 0.03% | 449 |
|
|
2017
Q1 | USD 5.07 M | Vender |
86,272
-21,044
| -20% | -USD 1.23 M | 0.03% | 416 |
|
|
2016
Q4 | USD 6.01 M | Vender |
107,316
-13,938
| -11% | -USD 803 k | 0.04% | 342 |
|
|
2016
Q3 | USD 7.47 M | Comprar |
121,254
+1,328
| +1% | +USD 87 k | 0.06% | 287 |
|
|
2016
Q2 | USD 7.6 M | Comprar |
119,926
+1,349
| +1% | +USD 84.8 k | 0.06% | 268 |
|
|
2016
Q1 | USD 7.12 M | Vender |
118,577
-243
| -0.2% | -USD 14.9 k | 0.06% | 277 |
|
|
2015
Q4 | USD 8.31 M | Vender |
118,820
-20,594
| -15% | -USD 1.46 M | 0.08% | 236 |
|
|
2015
Q3 | USD 9.25 M | Comprar |
139,414
+25,141
| +22% | +USD 1.96 M | 0.1% | 205 |
|
|
2015
Q2 | USD 8.95 M | Comprar |
114,273
+45,568
| +66% | +USD 3.55 M | 0.09% | 217 |
|
|
2015
Q1 | USD 5.25 M | Comprar |
68,705
+9,042
| +15% | +USD 665 k | 0.05% | 305 |
|
|
2014
Q4 | USD 3.97 M | Comprar |
59,663
+9,890
| +20% | +USD 659 k | 0.04% | 358 |
|
|
2014
Q3 | USD 3.17 M | Comprar |
49,773
+1,737
| +4% | +USD 107 k | 0.04% | 405 |
|
|
2014
Q2 | USD 2.93 M | Vender |
48,036
-27,239
| -36% | -USD 1.58 M | 0.04% | 422 |
|
|
2014
Q1 | USD 4.26 M | Comprar |
75,275
+37,380
| +99% | +USD 2.12 M | 0.06% | 288 |
|
|
2013
Q4 | USD 2.03 M | Comprar |
37,895
+13,227
| +54% | +USD 662 k | 0.03% | 494 |
|
|
2013
Q3 | USD 1.14 M | Comprar |
24,668
+10,399
| +73% | +USD 475 k | 0.02% | 656 |
|
|
2013
Q2 | USD 603 k | Comprar |
+14,269
| Nuevas | +USD 594 k | 0.01% | 936 |
|
Otros fondos que tienen PJP en su cartera
JGCM
Posición de Commonwealth Equity Services en PJP: resumen de T2 2026
Commonwealth Equity Services redujo su participación en Invesco Pharmaceuticals ETF (PJP) en 20% durante T2 2026, al vender acciones por un valor estimado de USD 219 k, y conservó 8,285 acciones valuadas en USD 981 k. La posición representa ﹤0.01% de la cartera y ocupa el puesto #2727.
Commonwealth Equity Services reportó por primera vez una posición en PJP en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 9.25 M en T3 2015. Al cierre de T2 2026, 116 fondos que sigue Wall St. Rank mantienen una posición en PJP.
- Al cierre de T2 2026, Commonwealth Equity Services tenía 8,285 acciones de Invesco Pharmaceuticals ETF con un valor de USD 981 k.
- Commonwealth Equity Services vendió 2,020 acciones de Invesco Pharmaceuticals ETF en T2 2026, por un valor estimado de USD 219 k.
- Invesco Pharmaceuticals ETF representó ﹤0.01% de la cartera de Commonwealth Equity Services en T2 2026 y fue su posición número 2727.
- Commonwealth Equity Services reportó por primera vez una posición en Invesco Pharmaceuticals ETF en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de Commonwealth Equity Services en Invesco Pharmaceuticals ETF alcanzó su máximo de USD 9.25 M en T3 2015.
- Al cierre de T2 2026, 116 fondos que sigue Wall St. Rank tenían Invesco Pharmaceuticals ETF en cartera.
Según el Informe 13F de Commonwealth Equity Services correspondiente a T2 2026, presentado el 29 jul 2026.